Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MYMD PHARMACEUTICALS, INC.

(MYMD)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Insider Buy: Mymd Pharmaceuticals

11/29/2021 | 02:08pm EST


ę MT Newswires 2021
All news about MYMD PHARMACEUTICALS, INC.
01/05MYMD PHARMACEUTICALS : Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method o..
PU
01/05MYMD PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
01/05MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method ..
BU
2021MYMD PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financia..
AQ
2021MyMD Pharmaceuticals Says Oravax Gets Pre-Purchase Order for Oral COVID-19 Vaccine in D..
MT
2021MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase A..
BU
2021SHAREHOLDER ALERT : Purcell Julie & Lefkowitz LLP Is Investigating MyMD Pharmaceuticals, I..
PR
2021MYMD PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
2021MyMD Pharmaceuticals to Participate in Two Investor Conferences During December 2021
BU
2021INSIDER BUY : Mymd Pharmaceuticals
MT
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -8,93 M - -
Net Debt 2020 2,89 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 183 M 183 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 6
Free-Float 93,3%
Chart MYMD PHARMACEUTICALS, INC.
Duration : Period :
MyMD Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MYMD PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Christopher C. Chapman President, Director & Chief Medical Officer
Ian Rhodes Chief Financial Officer
Joshua Nathaniel Silverman Chairman
Adam Kaplin Chief Scientific Officer
Paul Rivard Executive VP-Operations & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
MYMD PHARMACEUTICALS, INC.-19.80%183
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684